Ernexa Therapeutics director Robert J. Spiegel files initial beneficial ownership statement
ERNA•Director files initial Form 3
- Director Robert J. Spiegel filed an initial Form 3 at Ernexa Therapeutics, disclosing his insider status as of Sept. 14, 2026.
